Membranoproliferative glomerulonephritis in patients with cystic fibrosis: Coincidence or comorbidity? A case series

Southern Medical Journal

Volumn 101, Issue 6, 2008, Pages 641-645

  Soriano, Edwin ^a   Fischman, Daniel ^a   Cheriyath, Pramil ^a  

^a Harrisburg Hospital   (United States)

Author keywords

Cystic fibrosis; Membranoproliferative glomerulonephritis; MPGN; Renal failure

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; AZITHROMYCIN; AZTREONAM; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; COLISTIMETHATE; COMPLEMENT; COTRIMOXAZOLE; CYCLOSPORIN; DILTIAZEM; DIPYRIDAMOLE; DORNASE ALFA; FLUOROURACIL; FLUTICASONE PROPIONATE PLUS SALMETEROL; FOLINIC ACID; FUROSEMIDE; HYDRALAZINE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; LINEZOLID; LOSARTAN; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXALIPLATIN; PREDNISONE; STEROID; SUPERANTIGEN; TOBRAMYCIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; CASE STUDY; CLINICAL EVALUATION; COLON ADENOCARCINOMA; COLON CANCER; COMORBIDITY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; ELECTRON MICROSCOPY; FEMALE; FOLLOW UP; HEMATURIA; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY; LUNG DISEASE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; SIGMOID; URINALYSIS; ADENOCARCINOMA; BIOPSY; BLOOD; CANCER STAGING; COLON TUMOR; COMPLEMENT ALTERNATIVE PATHWAY; GLOMERULUS; IMMUNOLOGY; INNATE IMMUNITY; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; PATHOLOGY;

ADENOCARCINOMA; ADULT; BIOPSY; COMORBIDITY; COMPLEMENT PATHWAY, ALTERNATIVE; CYSTIC FIBROSIS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNITY, NATURAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MALE; NEOPLASM STAGING; SIGMOID NEOPLASMS; SUPERANTIGENS;

EID: 45149115009     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318172f697     Document Type: Article

References (20)

1. Gaffney K, Gibbons D, Keogh B, et al. Amyloidosis complicating cystic fibrosis. Thorax 1993;48:949-950.
2. Katz SM, Krueger LJ, Falkner B. Microscopic nephrocalcinosis in cystic fibrosis. N Engl J Med 1988;319:263-266.
3. Abramowsky CR, Swinehart GL. The nephropathy of cystic fibrosis. Hum Pathol 1982;13:934-939.
4. Allen JL. Progressive nephropathy in a patient with cystic fibrosis and diabetes. N Engl J Med 1986;315:764.
5. Stirati G, Antonelli M, Fofi C, et al. IgA nephropathy in cystic fibrosis. J Nephrol 1999;12:30-31.
6. Lahiri T. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis. Clin Chest Med 2007;28:307-318.
7. Yankaskas JR, Marshall BC, Sufian B, et al. Cystic fibrosis adult care consensus conference report. Chest 2004;125:1S-39S.
8. Chmiel JF, Konstan MW. Inflammation and anti-inflammatory therapies for cystic fibrosis. Clin Chest Med 2007;28:331-346.
9. Lau KK, Wyatt RJ. Glomerulonephritis. Adolesc Med Clin 2005;16:67-85.
10. Appel G, Cook T, Hageman G, et al. Membranoproliferative glomeru-lonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 2005;16:1392-1404.
11. Stephens SE, Rigden SPA. Cystic fibrosis and renal disease. Paediatr Respir Rev 2002;3:135-138.
12. Smith K, Alpers C. Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr Opin Nephrol Hypertens 2005;14:396-403.
13. Mueller-Ortiz S, Drouin S, Wetsel R. The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Infect Immun 2004;72:2899-2906.
14. Wisnieski JJ, Todd EW, Fuller RK, et al. Immune complexes and complement abnormalities in patients with cystic fibrosis. Am Rev Respir Dis 1985;132:770-776.
15. Muir A, Soong G, Sokol S, et al. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 2004;30:777- 783.
16. Shuto T, Furuta T, Oba M, et al. Promoter hypomethylation of toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells. FASEB J 2006;20:782-784.
17. Handa T, Iono T, Watanabe H, et al. Glomerulonephritis induced by methicillin-sensitive Staphylococcus aureus infection. Clin Exp Nephrol 2003;7:247-249.
18. Chaun H, Paty B, Nakielna EM, et al. Colonic carcinoma in two adult cystic fibrosis patients. Can J Gastroenterol 1996;10:440-442.
19. Paydas S, Balal M, Paydas S, et al. Glomerular disease in patients with malignant disease: four cases and review of literature. Ren Fail 2005; 1:1-6.
20. Yavuzsen T, Oztop I, Yilmaz U, et al. Case report gastric cancer diagnosed in a patient with cresentric glomerulonephritis. Gastric Cancer 2003;6:267-269.